27N0 Stock Overview
Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cannovum Cannabis AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.36 |
| 52 Week High | €7.50 |
| 52 Week Low | €1.58 |
| Beta | 0 |
| 1 Month Change | -44.86% |
| 3 Month Change | 47.50% |
| 1 Year Change | -64.24% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -90.17% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| 27N0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -1.2% |
| 1Y | -64.2% | -28.2% | 1.8% |
Return vs Industry: 27N0 underperformed the German Pharmaceuticals industry which returned -27% over the past year.
Return vs Market: 27N0 underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| 27N0 volatility | |
|---|---|
| 27N0 Average Weekly Movement | 40.6% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 27N0's share price has been volatile over the past 3 months.
Volatility Over Time: 27N0's weekly volatility has increased from 31% to 41% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Pia Marten | cannovum.com |
Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based therapies. The company was formerly known as Cannovum AG and changed its name to Cannovum Cannabis AG in April 2023.
Cannovum Cannabis AG Fundamentals Summary
| 27N0 fundamental statistics | |
|---|---|
| Market cap | €1.20m |
| Earnings (TTM) | -€102.11k |
| Revenue (TTM) | €1.82k |
0.0x
P/S Ratio0.0x
P/E RatioIs 27N0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 27N0 income statement (TTM) | |
|---|---|
| Revenue | €1.82k |
| Cost of Revenue | €13.78k |
| Gross Profit | -€11.96k |
| Other Expenses | €90.16k |
| Earnings | -€102.11k |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 27N0 perform over the long term?
See historical performance and comparison